Eno1-KO Mouse
一般名
Eno1-KO
製品ID
S-KO-01882
背景情報
C57BL/6JCya
系統ID
KOCMP-13806-Eno1-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Eno1-KO Mouse（カタログ番号S-KO-01882）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Eno1-KO
系統ID
KOCMP-13806-Eno1-B6J-VA
遺伝子名
製品ID
S-KO-01882
遺伝子別名
NNE, Eno-1, MBP-1
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 4
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000080926
NCBIトランスクリプトID
NM_023119
ターゲット領域
Exon 3~6
有効領域の大きさ
~4.0 kb
遺伝子研究の概要
Eno1, also known as α -Enolase or 2 -phospho -D -glycerate hydrolase, is a glycolytic enzyme. It catalyzes the conversion of 2 -phosphoglyceric acid to phosphoenolpyruvic acid during glycolysis, playing a crucial role in the Warburg effect [1,9]. Eno1 is involved in multiple pathways related to cancer development, such as regulating cellular energetic, tumor proliferation, apoptosis, immune evasion, and angiogenesis [1]. Genetic models like gene knockout (KO) or conditional knockout (CKO) mouse models are valuable for studying its functions.
In in vivo studies, knockdown of Eno1 decreased cancer cell proliferation and invasiveness in lung cancer models, indicating its role in promoting metastasis via HGFR and WNT signaling-driven epithelial-to-mesenchymal transition [5]. In hepatocellular carcinoma, Eno1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1 [4]. In liver carcinogenesis, Eno1 promotes tumorigenesis through YAP1-dependent arachidonic acid metabolism [2]. In hypoxic pulmonary hypertension, inhibition of Eno1 in endothelial cells restored hypoxia-induced endothelial dysfunction, suggesting its role in the pathogenesis [3]. In colorectal cancer, targeting the Eno1 pathway may be meaningful as Fusobacterium nucleatum activates lncRNA ENO1-IT1 to promote glycolysis and oncogenesis [6]. In bladder cancer, melatonin inhibits tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis, and Eno1 could be a predictive biomarker [7]. In colorectal cancer, the NSUN2/YBX1/m5C-ENO1 positive feedback loop promotes tumor progression through metabolic recoding [8].
In conclusion, Eno1 is a multifunctional protein with its glycolytic function being essential in cellular energy regulation. Model-based research, especially KO/CKO mouse models, has revealed its significant roles in cancer development, including promoting tumor proliferation, invasion, metastasis, and evading cell death mechanisms. Understanding Eno1's functions provides potential therapeutic targets for treating various cancers.
References:
1. Huang, Chen Kai, Sun, Ying, Lv, Lei, Ping, Yong. 2022. ENO1 and Cancer. In Molecular therapy oncolytics, 24, 288-298. doi:10.1016/j.omto.2021.12.026. https://pubmed.ncbi.nlm.nih.gov/35434271/
2. Sun, Linchong, Suo, Caixia, Zhang, Tong, Zhang, Huafeng, Gao, Ping. 2023. ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism. In Nature chemical biology, 19, 1492-1503. doi:10.1038/s41589-023-01391-6. https://pubmed.ncbi.nlm.nih.gov/37500770/
3. Shi, Yuqing, Liu, Jie, Zhang, Ruoyang, Sun, Ying, Wang, Chen. 2023. Targeting Endothelial ENO1 (Alpha-Enolase) -PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension. In Hypertension (Dallas, Tex. : 1979), 80, 1035-1047. doi:10.1161/HYPERTENSIONAHA.122.19857. https://pubmed.ncbi.nlm.nih.gov/37075135/
4. Zhang, Tong, Sun, Linchong, Hao, Yijie, Gao, Ping, Zhang, Huafeng. 2021. ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. In Nature cancer, 3, 75-89. doi:10.1038/s43018-021-00299-1. https://pubmed.ncbi.nlm.nih.gov/35121990/
5. Li, Hsin-Jung, Ke, Feng-Yi, Lin, Chia-Ching, Yang, Pan-Chyr, Wu, Han-Chung. 2021. ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling-Driven Epithelial-to-Mesenchymal Transition. In Cancer research, 81, 4094-4109. doi:10.1158/0008-5472.CAN-20-3543. https://pubmed.ncbi.nlm.nih.gov/34145039/
6. Hong, Jie, Guo, Fangfang, Lu, Shi-Yuan, Chen, Haoyan, Fang, Jing-Yuan. 2020. F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer. In Gut, 70, 2123-2137. doi:10.1136/gutjnl-2020-322780. https://pubmed.ncbi.nlm.nih.gov/33318144/
7. Shen, Dexin, Deng, Zhao, Liu, Wei, Xiao, Yu, Wang, Xinghuan. 2023. Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis. In Cell death & disease, 14, 246. doi:10.1038/s41419-023-05770-8. https://pubmed.ncbi.nlm.nih.gov/37024456/
8. Chen, Baoxiang, Deng, Yanrong, Hong, Yuntian, Zhao, Jianhong, Jiang, Congqing. 2024. Metabolic Recoding of NSUN2-Mediated m5C Modification Promotes the Progression of Colorectal Cancer via the NSUN2/YBX1/m5C-ENO1 Positive Feedback Loop. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2309840. doi:10.1002/advs.202309840. https://pubmed.ncbi.nlm.nih.gov/38769664/
9. Li, Yafei, Liu, Lu, Li, Bo. 2024. Role of ENO1 and its targeted therapy in tumors. In Journal of translational medicine, 22, 1025. doi:10.1186/s12967-024-05847-8. https://pubmed.ncbi.nlm.nih.gov/39543641/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。